| In vivo prevention of transplant arteriosclerosis by ex vivo–expanded human regulatory T cells SN Nadig, J Więckiewicz, DC Wu, G Warnecke, W Zhang, S Luo, ... Nature medicine 16 (7), 809-813, 2010 | 349 | 2010 |
| Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis A Schiopu, J Bengtsson, I Söderberg, S Janciauskiene, S Lindgren, ... Circulation 110 (14), 2047-2052, 2004 | 262 | 2004 |
| S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease A Schiopu, OS Cotoi Mediators of inflammation 2013, 2013 | 260 | 2013 |
| Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in Apobec-1−/−/low-density lipoprotein receptor−/− mice A Schiopu, B Frendéus, B Jansson, I Söderberg, I Ljungcrantz, Z Araya, ... Journal of the American College of Cardiology 50 (24), 2313-2318, 2007 | 209 | 2007 |
| Role of T cells in graft rejection and transplantation tolerance F Issa, A Schiopu, KJ Wood Expert review of clinical immunology 6 (1), 155-169, 2010 | 145 | 2010 |
| S100A9 links inflammation and repair in myocardial infarction G Marinković, DS Koenis, L de Camp, R Jablonowski, N Graber, ... Circulation research 127 (5), 664-676, 2020 | 119 | 2020 |
| Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals OS Cotoi, P Dunér, N Ko, B Hedblad, J Nilsson, H Björkbacka, A Schiopu Arteriosclerosis, thrombosis, and vascular biology 34 (1), 202-210, 2014 | 113 | 2014 |
| Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction G Marinković, H Grauen Larsen, T Yndigegn, IA Szabo, RG Mares, ... European heart journal 40 (32), 2713-2723, 2019 | 102 | 2019 |
| Circulating monocyte chemoattractant protein-1 and risk of stroke: meta-analysis of population-based studies involving 17 180 individuals MK Georgakis, R Malik, H Björkbacka, TA Pana, S Demissie, C Ayers, ... Circulation research 125 (8), 773-782, 2019 | 101 | 2019 |
| Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo J Hester, A Schiopu, SN Nadig, KJ Wood American Journal of Transplantation 12 (8), 2008-2016, 2012 | 96 | 2012 |
| Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection G Feng, SN Nadig, L Bäckdahl, S Beck, RS Francis, A Schiopu, ... Science translational medicine 3 (83), 83ra40-83ra40, 2011 | 87 | 2011 |
| Autoantibody against the amino acid sequence 661–680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events GN Fredrikson, A Schiopu, G Berglund, R Alm, PK Shah, J Nilsson Atherosclerosis 194 (2), e188-e192, 2007 | 77 | 2007 |
| A high quality diet is associated with reduced systemic inflammation in middle-aged individuals JA Dias, E Wirfält, I Drake, B Gullberg, B Hedblad, M Persson, G Engström, ... Atherosclerosis 238 (1), 38-44, 2015 | 73 | 2015 |
| Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease J Nilsson, G Nordin Fredrikson, A Schiopu, PK Shah, B Jansson, ... Current pharmaceutical design 13 (10), 1021-1030, 2007 | 64 | 2007 |
| Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease GN Fredrikson, B Hedblad, G Berglund, R Alm, JA Nilsson, A Schiopu, ... Stroke 38 (5), 1495-1500, 2007 | 58 | 2007 |
| Plasma procalcitonin and the risk of cardiovascular events and death: a prospective population‐based study A Schiopu, B Hedblad, G Engström, J Struck, NG Morgenthaler, ... Journal of internal medicine 272 (5), 484-491, 2012 | 56 | 2012 |
| Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100 Å Ström, GN Fredrikson, A Schiopu, I Ljungcrantz, I Söderberg, B Jansson, ... Atherosclerosis 190 (2), 298-305, 2007 | 49 | 2007 |
| Cardiac rehabilitation after acute myocardial infarction in Sweden–evaluation of programme characteristics and adherence to European guidelines: The Perfect Cardiac … H Ögmundsdottir Michelsen, I Sjölin, M Schlyter, E Hagström, A Kiessling, ... European journal of preventive cardiology 27 (1), 18-27, 2020 | 46 | 2020 |
| Transcriptional profiling and functional analysis of N1/N2 neutrophils reveal an immunomodulatory effect of S100A9-blockade on the pro-inflammatory N1 subpopulation AC Mihaila, L Ciortan, RD Macarie, M Vadana, S Cecoltan, MB Preda, ... Frontiers in Immunology 12, 708770, 2021 | 45 | 2021 |
| IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis D Engelbertsen, S Rattik, M Wigren, J Vallejo, G Marinkovic, A Schiopu, ... Cardiovascular research 114 (1), 180-187, 2018 | 38 | 2018 |
Jan NilssonProfessor of Experimental Cardiovascular Research, Lund UniversityVerified email at med.lu.se
